MVA-BN (Multi-Variant)
Prevention of COVID-19
Phase 2Active
Key Facts
About Bavarian Nordic
Bavarian Nordic is a publicly traded vaccine specialist with a firm focus on developing and manufacturing life-saving immunizations. The company has demonstrated strong commercial momentum, particularly in its Travel Health business, and has been a key supplier of a non-replicating smallpox/mpox vaccine for global public health stockpiles. Its strategy leverages a fully integrated model from R&D through manufacturing to address infectious disease threats.
View full company profileTherapeutic Areas
Other Prevention of COVID-19 Drugs
| Drug | Company | Phase |
|---|---|---|
| Recombinant COVID-19 Vaccine (ZF2001) | Zhifei Biological Products | Approved |
| Novel Coronavirus mRNA Vaccine | Zhifei Biological Products | Clinical |
| COVID-19 Inactivated Vaccine (BBIBP-CorV) | Tiantan Bio | Approved |
| Recombinant COVID-19 Vaccine | Tiantan Bio | Phase 3 |
| Oral COVID-19 Vaccine | Oramed Pharmaceuticals | Pre-clinical |
| DMAb-1 | Inovio Pharmaceuticals | Phase 1 |
| DMAb-2 | Inovio Pharmaceuticals | Phase 1 |
| SARS-CoV-2 Vaccine | Auro Vaccines | Poised for Clinical |